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Abstract
Background: The use of tobacco products including Swedish snus (moist snuff) in pregnancy may cause adverse
health outcomes. While smoking prevalence has decreased among fertile women in Norway, snus use has
increased during the last years. We investigated whether these trends were reflected also during pregnancy in a
population of women in Southern Norway.
Methods: Data on smoking tobacco and snus use at three time points before and during pregnancy for 20,844
women were retrieved from the electronic birth record for the years 2012–2017. The results for the three-year
period 2015–2017 were compared with a previously studied period 2012–2014. Prevalence and quit rates of
tobacco use within groups of age, parity and education were reported. Within the same groups adjusted quit rates
were analyzed using logistic regression. Mean birthweight and Apgar score of offspring were calculated for
tobacco-users and non-users.
Results: There was an increase of snus use before pregnancy from the period 2012–2014 to the period 2015–2017
from 5.1% (CI; 4.6 to 5.5) to 8.4% (CI; 7.8 to 8.9). Despite this, the use of snus during pregnancy did not increase
from the first to the second period, but stabilized at 2.8% (CI; 2.5 to 3.2) in first trimester and 2.0% (CI; 1.7 to 2.2) in
third trimester. Cigarette smoking decreased significantly both before and during pregnancy. Snus use and smoking
during pregnancy were associated with a reduction in average birthweight, but no significant effects on Apgar
scores. Odds ratios for quitting both snus and smoking tobacco during pregnancy were higher for women aged
25–34 years, for the primiparas and for those with a high level of education. Pregnant women were more likely to
have quit tobacco use in the last time period compared to the first.
Conclusions: While smoking during pregnancy was decreasing, the use of snus remained constant, levelling off to
around 3% in first trimester and 2% in third trimester. Approximately 25% of those that used snus, and 40% that
smoked before pregnancy, continued use to the third trimester. This calls for a continuous watch on the use of
snus and other nicotine products during pregnancy.
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Background
The use of smoking tobacco has declined for decades in
Norway. At the same time, the use of Swedish snus (moist
snuff) has increased among young adults and especially in
the last decade for women. In 2017, 15% of Norwegian
women aged 16–44 years used snus daily or occasionally
and likewise 14% used smoking tobacco [1, 2]. The health
consequences from cigarette smoking in pregnancy are
well known [1, 3–5]. Adverse health outcomes from use
of snus during pregnancy are documented in recent years,
especially from large population studies based on the
Swedish Medical Birth Register. Snus use during preg-
nancy may increase risks of stillbirth, premature birth and
small-for-gestational-age [3, 6–9], and is also associated
with increased risk of oral cleft malformation and apnea
in the newborn [4, 10, 11].
Due to long traditions of using and manufacturing snus,
Sweden is granted a permanent exemption from the sales
ban on snus in the European Union. Since Norway is not
a member of the EU, snus is legally sold here too. Smok-
ing in pregnancy has been reported in the Medical Birth
Registry (MBR Norway) since 1999, and the prevalence
has declined since the registration started [12]. National
data on the use of snus in pregnancy is still not reported
in the MBR Norway, although it has been registered in the
electronic birth records (EBRs) and in the Health card for
pregnant women (HCPW) Nationally since 2014. Thus,
there is little knowledge on the extent of snus use in preg-
nancy in Norway. A register study from Southern Norway
including the years 2012–2014 showed that the use of
snus almost doubled during those three years, where 2%
of women used snus and 7% smoked tobacco through
pregnancy [13]. In a questionnaire study from Scandi-
navia, 6.5% used snus alone, and 4,8% used any other
nicotine product at some time in pregnancy [14].
The aims of this study were to investigate self-
reported tobacco use before and during pregnancy in
the period 2015–2017, and to compare with the period
2012–2014 in the same region in Southern Norway [13],
and further to identify potential predictors of tobacco
use and cessation in sociodemographic groups. On the
basis of the general trends in society [1, 2] and the previ-
ous study [13], our hypothesis was that there would be
an increase in the proportion of snus use in pregnancy,
but that a larger proportion of tobacco users would quit
snus than cigarette smoking during pregnancy. We also
compared birthweight and Apgar score in offspring of
mothers who were users and non-users of snus or smok-
ing tobacco in third trimester. As there is an ongoing
shift from smoking tobacco to snus and newer nicotine
products among young women of reproductive age in
many countries, there is a need for more knowledge
about the use in pregnancy and its consequences in clin-
ical and preventive medicine.
Methods
De-identified data were retrieved from the EBR for all
women aged 16–44 years who gave birth in the years
2012–2017 at Sørlandet Hospital, comprising the mater-
nity wards at three different hospitals located in the
Agder counties in Southern Norway. The catchment
area covers approximately 300,000 inhabitants. Almost
all births in Norway take place in public institutions, and
the majority in the local maternity ward.
The Norwegian Directorate of Health has drafted a
standardized health record, “Health card for pregnant
women” (HCPW) to be used in primary care. Health
personnel interviewed the women about snus use and
cigarette smoking at the first antenatal check-up and re-
corded this into the prescribed form as: “no”, “occasion-
ally” or “daily”. This information was later transferred to
the Hospital EBR as tobacco use “before pregnancy”. To-
bacco use “in the first trimester” was registered into EBR
by midwifes at the routine ultrasound check-up around
week 18. Tobacco use “in the third trimester” was regis-
tered into EBR at the admission in the maternity ward.
Since no objective measures confirmed quitting or ab-
stinence, the information is referred to as self-reported.
In this study we report daily and occasional tobacco use
combined. We also report dual use of both snus use and
smoking, which includes either a combination of both
products occasionally, or one product daily and the
other occasionally, or both products daily. Maternal age
was grouped as: “16–24 years”, “25–34 years” and “35–
44 years”. Parity was grouped as: “no previous birth”,
“one previous birth” and “two or more previous births”.
The self-reported highest achieved educational level at
the time of pregnancy was recorded in the HCPW in
three groups: “primary/lower secondary education” (less
than high school), “upper secondary” (high school)” and
“higher education” (university education or more than 4
years of college). Only women with complete data about
tobacco use at all three registration points were included
in the study population, and were followed from “before
pregnancy” to “first trimester” and to “third trimester”.
The three variables age, parity and education from the
main descriptive results of tobacco prevalence and quit-
ting, were also considered as predictor variables in the ad-
justed analyses of quit rates. Age, parity and education
have been indicated as possible determinants of smoking
cessation in pregnancy [15, 16]. As the prevalence of snus
use is rising while smoking is decreasing [12, 13], we
found the possibility to study also the tendency to quit to-
bacco in a time perspective important. Thus, we included
the birth year of the newborn in the adjusted analyses.
Statistical analysis
Data retrieval was undertaken by Sykehuspartner (the
Hospital’s ICT Trust), transferred to the Norwegian
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Institute of Public Health, and analyzed with STATA
(version 15).
The three-year-periods 2015–2017 and 2012–2014
were analyzed separately and compared. The use of snus
and smoking tobacco before pregnancy, in the first and
third trimester were presented as prevalence (95% CI) in
groups of age, parity, and education. The proportions of
switching from snus to cigarettes, or opposite, were also
calculated.
The quit rates (95% CI) were calculated as the propor-
tion of women who reported tobacco use before preg-
nancy (N1), but no tobacco use in the first trimester
(N2) or no tobacco use in the third trimester (N3): Quit
rates from before pregnancy to first trimester: N1-N2/
N1*100. Quit rates from before pregnancy to third tri-
mester: N1-N3/N1*100. In addition to presenting preva-
lence and quit rates for the women that were dual users
of both snus and smoking tobacco, we analyzed the pro-
portion that quit both products or that continued just
one of the products.
Logistic regression was applied in the multivariable ana-
lyses for quit rates. The study population for the whole
period 2012–2017 was included in separate analyses for
snus use and smoking tobacco. The outcome variable for
quitting snus use or not was: 0) “continued snus use in
third trimester” and 1) “no snus use in third trimester”.
The outcome variable for quitting smoking or not was: 0)
“continued smoking in third trimester” and 1) “no smok-
ing in third trimester”. These 0/1 outcome variables corre-
sponded to the quit rates among women who reported
tobacco use before pregnancy, but no tobacco use in the
third trimester. The outcome measures “Odds Ratios”
(OR) were given with confidence intervals (95% CI) and
P-values. In the regression analyses, the predictor variables
age, parity and education were all categorized with three
levels as explained above in the previous section. Time
period, based on birth year of the newborn, was included
as predictor-variable with the years 2015–2017 versus the
years 2012–2014. In addition to the logistic regression,
quit rates in percent were calculated for the entire period
2012–2017, representing the unadjusted values of tobacco
quitting.
For the period 2015–2017 mean birth weights with
confidence intervals and P-values (95% CI) for offspring
of snus users and smokers were compared to mean birth
weight for offspring of the non-tobacco users in third
trimester. Here, all women in the age 16–44 years with
records of snus use or cigarette smoking in the third tri-
mester were included in the calculations, not only those
with complete records of both snus use and smoking at
all three time points. Newborns with birth weight below
500 g were not included in the analyses (unviable births).
Corresponding analyses with mean values (95% CI) were
performed for Apgar score.
Results
In the period 2012–2017 there were 20,844 births at
Sørlandet hospital, comprising 5.9% of all births in
Norway in these years. Missing values for snus use before
pregnancy, in first and third trimester were 1.2, 2.2 and
3.2%, respectively. Correspondingly, missing values for
smoking tobacco were 1.1, 0.5 and 2.5%; for Apgar score
1min and 5min 0.3% for both time points, and for Apgar
score 10min 1.4%. For birthweight, missing information
constituted 0.3%, including omitted births with infant
weight below 500 g (N = 58). Missing information on edu-
cation was 6.9%; 8.6% in the age group 16–24 years, 5.8%
in the age group 25–34 years and 7.7% in the age group
35–44 years.
Women below age 16 (n = 2) and above age 44 (n =
40), were excluded from the study population. The study
population cohort constituted 19,767 women (95% of all
20,844) who had complete reports of tobacco use, 9912
in the period 2012–2014 and 9855 in 2015–2017.
Time trends
Time trends for the prevalence of pregnancy tobacco
use comprising the six years 2012–2017 are visualized in
Fig. 1. Further, time trends comparing the three-year pe-
riods 2015–2017 and 2012–2014 are presented in Table 1
and Additional file 1: Table S1. Comparing the two
three-year periods, there was an increase in the self-
reported snus use before pregnancy from 5.1% (CI; 4.6
to 5.5) to 8.4% (CI 7.8 to 8.9). Despite this, use of snus
during pregnancy in the last period remained unchanged
compared to the first period, with 2.8% in the first tri-
mester and 2.0% in the third trimester. For cigarette
smoking there was a reduction before pregnancy from
19.2% (CI; 18.5 to 20.0) in the first period to 12.8% (CI;
12.1 to 13.5%) in the last period. Correspondingly, in the
third trimester smoking was reduced from 8.1% (CI; 7.6
to 8.7) to 5.0% (CI; 4.6 to 5.5) (Table 1, Additional file 1:
Table S1).
Pregnancy tobacco use in the period 2015–2017
In the youngest age group 16–24 years 20.5% used snus
before pregnancy, while the corresponding prevalence
in the age group 25–34 years was 7.5%. (Table 1). Like-
wise, 21.2% of the youngest smoked before pregnancy,
while the corresponding prevalence for the 25–34 year
group was 11.7% (Table 1). Only 1.4% of the women
reported dual use of both snus and smoking tobacco
before pregnancy, and the proportion was below 1%
during pregnancy. Dual use was most marked among
the youngest aged 16–24 years, approximating to 5%
before pregnancy (Table 1).
While the prevalence of snus use before pregnancy
was highest in women with upper secondary education,
cigarette smoking was most prevalent among women
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with primary/lower secondary education. No difference
in snus use during pregnancy (first and third trimester)
was found between women with primary and secondary
education. Women with higher education had the lowest
prevalence of snus use at all three time points. The edu-
cational differences in smoking prevalence were pro-
nounced at all three time points before and during
pregnancy. Around 6% of women with higher education
were tobacco users prior to pregnancy (snus and/or
smoke), but the prevalence was only 1–2% during preg-
nancy (Table 1).
Quit rates
Out of 824 women who had used snus prior to preg-
nancy in the period 2015–2017, 66.4% had quit by the
first trimester and 76.7% by the third trimester. Out of
1259 who smoked before pregnancy, 52.6% had quit by
the first trimester and 60.5% by the third trimester.
Thus, a larger proportion had quit snus than smoking
tobacco during pregnancy (Table 2).
Compared to the previous three-year period 2012–
2014 (Additional file 2: Table S2), a larger proportion
had quit snus by first trimester in the period 2015–2017:
66.4% vs 51.3%. Correspondingly, in the third trimester
the figures were 76.7% vs 66.1%, respectively. The pro-
portions that quit smoking by first trimester were 52.6%
in the last period compared to 44.9% in the first period.
Corresponding figures for the third trimester were 60.5%
vs 57.7%, respectively. Hence, the bivariate analyses
showed higher quit rates for snus use during pregnancy
in the last period compared to the first, while the same
was not true for smoking by the third trimester (Table 2,
Additional file 2: Table S2).
The quit rates for dual use were 76.8% from before
pregnancy to first trimester, and 90.8% from before
pregnancy to third trimester (Table 2). However, the
dual users partly switched to use only one tobacco
product. When taking this into account, 46.5% of the
dual users had quit all tobacco by first trimester and
60.6% by third trimester. We also found that 3.6% of
the women who had used snus before pregnancy had
switched from snus use to smoking by third trimester.
Correspondingly, 2.2% had switched from smoking to
snus use by third trimester (data not shown). Lower
quit rates, but generally the same pattern of switching
among the dual users were found in the first period
(59.1% by first trimester and 81.1% by third trimester,
see Additional file 2: Table S2).
Table 3 shows unadjusted quit rates in percent and ad-
justed ORs for quitting snus use and smoking during
pregnancy for the whole period 2012–2017. Women
aged 25–34 years had higher ORs for quitting both snus
and smoking tobacco than women aged 16–24 years.
Women with no previous children (parity 0) were more
likely to quit snus and smoking tobacco than those with
previous births. Women with higher education were
most likely to quit snus or smoking during pregnancy,
however more so for smoking (OR > 5) than for snus use
(OR > 4). Pregnant women were more likely to have quit
tobacco use during pregnancy in the last period (2015–
2017), compared to the first (2012–2014).
Birth weight
The study population for analyzing differences in birth
weight for the period 2015–2017 was 102,011 women. The
average birthweight for children of tobacco-free mothers in
Fig. 1 Time trends in snus use and cigarette smoking among pregnant women 2012–2017. Percent
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the third trimester (n= 9213) was 3524 g (CI; 3513 to 3535).
The average birthweight for children of mothers who had
been daily or occasional smokers during third trimester (n=
506) was 3278 g (CI; 3229 to 3328, P-value <0.001), thus a
statistically significant reduction of 246 g in birthweight.
Average birthweight for children of mothers who had used
Table 1 Snus use and cigarette smoking among pregnant women 2015–2017.a Age 16–44 years. Percent, 95% Cl. N = 9855
Before pregnancy First trimester Third trimester
N % CI N % CI N % CI
Snus use, all
Snus use, occasional (n = 9855) 159 1.6 1.4–1.9 108 1.1 0.9–1.3 72 0.7 0.6–0.9
Snus use, daily (n = 9855) 665 6.7 6.3–7.3 169 1.7 1.5–2.0 120 1.2 1.0–1.5
Snus use, daily and occasional (n = 9855) 824 8.4 7.8–8.9 277 2.8 2.5–3.2 192 2.0 1.7–2.2
Snus use in age groups
16–24 years (n = 1285) 264 20.5 18.4–22.9 103 8.0 6.6–9.6 75 5.8 4.6–7.3
25–34 years (n = 6660) 500 7.5 6.9–8.2 153 2.3 2.0–2.7 104 1.6 1.3–1.9
35–44 years (n = 1910) 60 3.1 2.4–4.0 21 1.1 0.7–1.7 13 0.7 0.4–1.2
Snus use in groups of parity
No previous child (n = 3922) 512 13.1 12.0–14.1 144 3.7 3.1–4.3 96 2.4 2.0–3.0
One previous child (n = 3570) 226 6.3 5.6–7.2 93 2.6 2.1–3.2 65 1.8 1.4–2.3
Two or more previous children (n = 2363) 86 3.6 2.9–4.5 40 1.7 1.2–2.3 31 1.3 0.9–1.9
Snus use in educational groups b
Primary/lower secondary (n = 734) 60 8.2 6.3–10.4 36 4.9 3.5–6.7 25 3.4 2.2–5.0
Upper secondary (n = 3541) 412 11.6 10.6–12.7 161 4.5 3.9–5.3 125 3.5 2.9–4.2
Higher education (n = 4987) 314 6.3 5.6–7.0 63 1.3 1.0–1.6 32 0.6 0.4–0.9
Smoking, all
Smoking, occasional (n = 9855) 285 2.9 2.6–3.2 101 1.0 0.8–1.2 90 0.9 0.7–1.1
Smoking, daily (n = 9855) 974 9.9 9.3–10.5 496 5.0 4.6–5.5 407 4.1 3.7–4.5
Smoking, daily or occasional (n = 9855) 1259 12.8 12.1–13.5 597 6.1 5.6–6.5 497 5.0 4.6–5.5
Smoking in age groups
16–24 years (n = 1285) 272 21.2 19.0–23.5 136 10.6 9.0–12.4 109 8.5 7.0–10.1
25–34 years (n = 6660) 780 11.7 10.9–12.5 351 5.3 4.7–5.8 294 4.4 3.9–4.9
35–44 years (n = 1910) 207 10.8 9.5–12.3 110 5.8 4.8–6.9 94 4.9 4.0–6.0
Smoking in groups of parity
No previous child (n = 3922) 570 14.5 13.4–15.7 227 5.8 5.1–6.6 184 4,7 4.1–5.4
One previous child (n = 3570) 409 11.5 10.4–12.5 203 5.7 4.9–6.5 170 4,8 4.1–5.5
Two or more previous children (n = 2363) 280 11.9 10.6–13.2 167 7.1 6.1–8.2 143 6,1 5.1–7.1
Smoking in educational groups b
Primary/lower secondary (n = 734) 187 25.5 22.4–28.8 124 16.9 14.3–19.8 108 14.7 12.2–17.5
Upper secondary (n = 3541) 713 20.1 18.0–21.5 348 9.8 8.9–10.9 296 8.4 7.5–9.3
Higher education (n = 4987) 275 5.5 4.9–6.2 75 1.5 1.2–1.9 59 1.2 0.9–1.5
Dual use, all 142 1.4 1.2–1.7 33 0.3 0.2–0.5 13 0.1 0.1–2.3
Dual use in age groups
16–24 years (n = 1285) 61 4.8 3.7–6.1 14 1.1 0.6–1.8 2 0.2 0.0–0.6
25–34 years (n = 6660) 72 1.1 0.8–1.4 18 1.1 0.2–0.4 9 0.1 0.1–0.3
35–44 years (n = 1910) 9 0.5 0.2–0.9 1 1.1 0.0–0.3 2 0,1 0.0–0.4
aTobacco use: daily and occasional use combined
bIn comparing the levels of completed education, the age 25+ is often used in official statistics in Norway, as most people then are considered to have completed
their education. As pregnancy may prevent or delay the completion of education, we included all ages in the calculations of educational level in this study. This
may also give a truer picture of the predominantly young snus users
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snus daily or occasionally in the third trimester (n= 201)
was 3418 g (CI; 3338 to 3498, P-value <0.006 ), thus a
smaller, but also a statistically significant reduction in aver-
age birthweight of 106 g. We studied the distribution of
birth weight in groups of maternal age, parity and education.
Significant lower birth weight was found in children of
smoking mothers than in the non-tobacco users in all three
age groups, as well as in all groups of parity and education
(Additional file 3). The difference in birth weight between
children of snus users and non-tobacco users was statisti-
cally significant among mothers aged 16–24 years and
among those with upper secondary education. Snus users
with parity 0 contributed more than the other groups to the
reduced birth weight (Additional file 3).
There were no statistically or clinically significant dif-
ferences in Apgar scores in children of mothers who had
used snus or smoked cigarettes during pregnancy com-
pared to the non-tobacco users.
Discussion
This study on self-reported tobacco use showed that the
proportion that used snus before pregnancy more than
doubled from 2012 until 2017. The proportion that used
snus during pregnancy increased moderately in the years
2012–2014, but then remained quite constant from 2015
to 2017. This implies that the increase in snus use in the
general population in the period 2015–2017 was not
mirrored by a corresponding increase during pregnancy.
Table 2 Quit rates for pregnancy snus use and cigarette smoking 2015–2017.a Age 16–44 years. Percent, 95% Cl. N = 9855.
From before pregnancy to
first trimester
From before pregnancy to
third trimester
% CI % CI
Snus use, all 16–44 years
(N = 824 before pregnancy)
66.4 63–70 76.7 74–80
Snus use, age groups
16–24 years 61.0 55–67 71.6 66–77
25–34 years 69.4 65–73 79.2 75–83
35–44 years 65.0 52–77 78.3 66–88
Snus use, groups of parity
No previous child 71.9 68–76 81.3 78–85
One previous child 58.8 52–65 71.2 65–77
Two or more previous children 53.5 42–64 64.0 53–74
Snus use, educational groups
Primary/lower secondary 40.0 28–53 58.3 45–71
Upper secondary 60.9 56–66 69.7 65–74
Higher education 79.9 75–84 89.8 86–93
Smoking, all 16–44 years
(N = 1259 before pregnancy)
52.6 50–55 60.5 58–63
Smoking, age groups
16–24 years 50.0 44–56 59.9 54–66
25–34 years 55.0 51–59 62.3 59–66
35–44 years 46.9 40–54 54.6 48–62
Smoking, groups of parity
No previous child 60.2 56–64 67.7 64–72
One previous child 50.4 45–66 58.4 53–63
Two or more previous children 40.4 35–46 48.9 43–55
Smoking, educational groups
Primary/lower secondary 33.7 27–41 42.2 35–50
Upper secondary 51.2 47–55 58.5 55–62
Higher education 72.7 67–78 78.5 73–83
Dual use, all 16–44 years b
(N = 142 before pregnancy)
76.8 69–83 90.8 85–95
aTobacco use: daily and occasional use combined
bThe quit rates for dual use include those who quit both products, as well as those who quit only one of the products. See text description
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The use of smoking tobacco declined both before preg-
nancy and during pregnancy in the same period. A lar-
ger proportion of tobacco users quit snus than smoking
tobacco during pregnancy in both time periods.
The strength of this study lies in the large study popu-
lation, with complete information about tobacco use at
three time points before and during pregnancy from the
participating cohort of women. Another strength is the
low rates of missing information. It would be a further
strength if the study had been nationwide, but National
reporting of snus use in pregnancy is still not imple-
mented in Norway. This fact implies a greater demand
for regional data on snus use during pregnancy. An ob-
jective measure of quitting/abstinence from snus or
smoking (cotinine) would also have increased the valid-
ity and the general applicability of our results. At the na-
tional level, the use of snus among non-pregnant women
was higher than the observed prevalence before preg-
nancy in our study. Also, the prevalence of smoking at
the beginning of the first trimester was lower for
Norway as a whole than for our study population in
Southern Norway [17]. One explanation may be that
women in this region traditionally have had lower preva-
lence of snus use and higher use of smoking tobacco
than the national averages [1, 2]. There could also have
been an under-reporting in our study because of the
stigma associated with tobacco use in pregnancy. Gun-
nerbeck et al. found that the Swedish MBR misclassified
almost 45% of the cotinine-verified users of snus as non-
users in late pregnancy [18], while Mattsson et al. found
a high agreement between cotinine levels and smoking
data in the Swedish MBR [19]. Whether there is a pos-
sible, systematic underreporting of tobacco use in the
MBRs is a task for further research. Finally, we may as-
sume that the lower snus prevalence seen in this study
partly indicate that young women quit or restrain from
tobacco products not only during pregnancy, but also
prior to pregnancy, and especially in the period when
they plan to get pregnant [20].
There has been increased focus in recent years on the
harmful effects of snus in pregnancy. In spring 2016, the
Norwegian Directorate for Health launched a media
campaign against snus use in pregnancy, which was cited
nationwide in newspapers as well as on the web and
television. We have scarce information whether snus use
has become a topic in antenatal care in Norway. But re-
vision of routines after 2014, where the HCPW now also
calls for registration of snus use from the first antenatal
check-up, may also have contributed to augmented
awareness, both among the women and among health
personnel.
Snus use among Norwegian non-pregnant women in
fertile age was approximately the double of that in
Sweden [2, 21]. In our study population of pregnant
women in Southern Norway the prevalence of snus use
in the first trimester was about threefold of that in
Sweden: 3,0% versus 1,2% in 2016 [22]. This indicates
that snus use among women has become a larger
Table 3 Quit ratesa for tobacco use during pregnancy 2012–2017, expressed as percent (unadjusted) and OR (adjusted)
Snus users (n = 1325 before pregnancy) Smokers (n = 3165 before pregnancy)
% OR 95% CI P-value % OR 95% CI P-value
Age groups
16–24 years 67.1 1 Ref – 54.4 1 Ref –
25–34 years 75.7 1.38 1.00–1.89 0.051 61.2 1.29 1.06–1.58 0.011
35–44 years 75.3 1.69 0.84–3.42 0.142 56.8 1.15 0.86–1.54 0.331
Parity
Two or more previous children 61.0 1 Ref – 45.9 1 Ref –
One previous child 66,8 1.02 0.62–1.68 0.941 56.7 1.56 1.25–1.94 0.000
No previous children 76.9 2.00 1.22–3.28 0.006 66.0 2.55 2.04–3.19 0.000
Education
Primary, lower secondary 57.0 1 Ref – 42.6 1 Ref –
Upper secondary 64.5 1.30 0.83–2.03 0.248 55.3 1.64 1.33–2.02 0.000
Higher education 86.8 4.34 2.57–7.33 0.000 80.0 5.18 3.94–6.83 0.000
Time period
2012–2014 66.1 1 Ref – 57.7 1 Ref –
2015–2017 76.7 1.70 1.28–2.24 0.000 60.5 1.18 1.00–1.38 0.044
Note: Time period with all six years as a continuous variable gave minimal changes to the ORs compared to the dichotomous variable in the model above. Only
predictors found to alter the ORs were included in the main analyses. Interaction between the predictors parity and mothers age was tested, but was not found
to be statistically significant
aWomen who reported tobacco use before pregnancy, but no tobacco use in third trimester
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problem in Norway than in Sweden. The prevalence of
smoking in Norway and Sweden was comparable, ap-
proximately 15% among non-pregnant women 16–44
years in 2016, and in the first trimester around 5% in
both countries [17].
The reduction in birthweight by snus use and smoking
tobacco in this study was not adjusted for potential con-
founders like gestational age, since our dataset did not
include information on this. The observed difference in
birth weight between snus users and non-tobacco users
in our study population seem mainly to be influenced by
women in the youngest age group and those with
medium education and no previous child. The associ-
ation of birth weight reduction by snus use in pregnancy
is debated, and recent studies indicate that smokeless
tobacco use has minor effects on birth weight [23, 24].
The lack of difference in Apgar score between the
cigarette smokers/snus users and the tobacco-free
groups is to our knowledge not reported previously.
Cigarette smoking and snus use before and during
pregnancy was most prevalent at young age and lower
educational level. But snus use before and in pregnancy
was also prevalent among women with intermediate
education. This is consistent with findings among non-
pregnant women in Norway [25]. Smokers with primary
and upper secondary education constituted the bulk of
tobacco use, both before and during pregnancy. Overall,
77% of the women using snus and 61% of the cigarette
smokers had stopped by the third trimester. In a recent
study from Scandinavia (Oslo and Stockholm), the quit
rates were even higher, possibly because here the partici-
pants mainly were recruited from urban populations
[14]. In our study, higher education was a powerful pre-
dictor of quitting, regarding both snus use and smoking.
The same was true for women delivering their first baby
compared to those of previous parity. This was in ac-
cordance with findings in a study about smoking in
pregnancy from the US [16].
We found low prevalence for dual use in the studied
population compared to studies among non-pregnant
women [25, 26]. A comparable low prevalence of dual
use in pregnancy was found in the Scandinavian study
[14]. Among the women reporting dual use before preg-
nancy in our study, there was a shift towards a higher
proportion being “smokers only” compared to “snus
users only” in the third trimester from the first three-
year period to the second. This may be a result of the
increased focus of the harmful effects of snus as men-
tioned above.
Although the proportion that quit snus and smoking
tobacco increased in the last 3-year period, still a consid-
erable proportion of women who smoked or used snus
before pregnancy continued through pregnancy. A por-
tion of snus, as it is sustained longer in the mouth, may
result in a higher and longer-lasting concentration of
nicotine in the blood than a smoked cigarette. Nicotine
quickly passes through the placenta barrier, and in one
study nicotine concentration was 15% higher in the fetal
than in the maternal plasma [27]. Perinatal snus expos-
ure has shown long-term effect on cardiovascular func-
tion in the child [28]. Nicotine exposure in pregnancy
may also have adverse effects on fetal brain and lung de-
velopment [29, 30]. Since no lower threshold of harmful
effect of nicotine on the fetus or child is known, this
represents a potential public health challenge [31]. In
North America there has been an increase in use of
moist snuff and other nicotine delivery products [32].
Advice on the harmful effects of all nicotine products
should therefore be provided to adolescent girls. A pos-
sible arena for information may be in the context of con-
sultations on contraception.
Assuming that the trends in the period 2015–2017
continue, our study may give a small indication that
Norway might be heading towards tobacco-free preg-
nancies. However, we are far from there yet. Snus use is
a relatively recent trend among women in Norway.
Many have started at an early age and are not concur-
rent smokers [25]. Snus and new nicotine products like
e-cigarettes are advocated as harm reduction products
to cigarette smokers [33]. The Scandinavian countries,
especially Sweden and Norway, have been a niche for
the sale of snus. The tobacco industry is fighting to
open legal sales in the rest of the EU. Unfortunately,
often when snus is promoted as a less harmful substi-
tute for smoked tobacco, the potential harmful effects
of nicotine exposure in pregnancy seem clearly under-
communicated [34].
Conclusion
While smoking decreased, the use of snus during preg-
nancy remained constant in this study. The quit rates for
snus were higher than for smoking tobacco. The OR for
quitting both snus and cigarettes were higher for women
aged 25–34 years, for woman delivering their first baby
and for those with higher education. Around one in four
of the snus users and two of five of the smokers continued
through pregnancy, which implies a need for surveillance
and preventive measures regarding the use of snus and
other nicotine products during pregnancy.
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